TY - JOUR
T1 - Uniform definition of asthma severity, control, and exacerbations
T2 - Document presented for the World Health Organization Consultation on Severe Asthma
AU - Bousquet, Jean
AU - Mantzouranis, Eva
AU - Cruz, Alvaro A.
AU - Aït-Khaled, Nadia
AU - Baena-Cagnani, Carlos E.
AU - Bleecker, Eugene R.
AU - Brightling, Chris E.
AU - Burney, Peter
AU - Bush, Andrew
AU - Busse, William W.
AU - Casale, Thomas B.
AU - Chan-Yeung, Moira
AU - Chen, Rongchang
AU - Chowdhury, Badrul
AU - Chung, Kian Fan
AU - Dahl, Ronald
AU - Drazen, Jeffrey M.
AU - Fabbri, Leonardo M.
AU - Holgate, Stephen T.
AU - Kauffmann, Francine
AU - Haahtela, Tari
AU - Khaltaev, Nikolaï
AU - Kiley, James P.
AU - Masjedi, Mohammad R.
AU - Mohammad, Yousser
AU - O'Byrne, Paul
AU - Partridge, Martyn R.
AU - Rabe, Klaus F.
AU - Togias, Alkis
AU - Van Weel, Christiaan
AU - Wenzel, Sally
AU - Zhong, Nanshan
AU - Zuberbier, Torsten
N1 - Funding Information:
In collaboration with the Global Allergy and Asthma European Network (GA 2 LEN), supported by the Sixth EU Framework program for research (contract no. FOOD-CT-2004-506378 ) and the World Health Organization Collaborating Center on Asthma and Rhinitis, Montpellier .
PY - 2010/11
Y1 - 2010/11
N2 - Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic groups and countries. It is estimated that around 250,000 people die prematurely each year as a result of asthma. Concepts of asthma severity and control are important in evaluating patients and their response to treatment, as well as for public health, registries, and research (clinical trials, epidemiologic, genetic, and mechanistic studies), but the terminology applied is not standardized, and terms are often used interchangeably. A common international approach is favored to define severe asthma, uncontrolled asthma, and when the 2 coincide, although adaptation may be required in accordance with local conditions. A World Health Organization meeting was convened April 5-6, 2009, to propose a uniform definition of severe asthma. An article was written by a group of experts and reviewed by the Global Alliance against Chronic Respiratory Diseases review group. Severe asthma is defined by the level of current clinical control and risks as "Uncontrolled asthma which can result in risk of frequent severe exacerbations (or death) and/or adverse reactions to medications and/or chronic morbidity (including impaired lung function or reduced lung growth in children)." Severe asthma includes 3 groups, each carrying different public health messages and challenges: (1) untreated severe asthma, (2) difficult-to-treat severe asthma, and (3) treatment-resistant severe asthma. The last group includes asthma for which control is not achieved despite the highest level of recommended treatment and asthma for which control can be maintained only with the highest level of recommended treatment.
AB - Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic groups and countries. It is estimated that around 250,000 people die prematurely each year as a result of asthma. Concepts of asthma severity and control are important in evaluating patients and their response to treatment, as well as for public health, registries, and research (clinical trials, epidemiologic, genetic, and mechanistic studies), but the terminology applied is not standardized, and terms are often used interchangeably. A common international approach is favored to define severe asthma, uncontrolled asthma, and when the 2 coincide, although adaptation may be required in accordance with local conditions. A World Health Organization meeting was convened April 5-6, 2009, to propose a uniform definition of severe asthma. An article was written by a group of experts and reviewed by the Global Alliance against Chronic Respiratory Diseases review group. Severe asthma is defined by the level of current clinical control and risks as "Uncontrolled asthma which can result in risk of frequent severe exacerbations (or death) and/or adverse reactions to medications and/or chronic morbidity (including impaired lung function or reduced lung growth in children)." Severe asthma includes 3 groups, each carrying different public health messages and challenges: (1) untreated severe asthma, (2) difficult-to-treat severe asthma, and (3) treatment-resistant severe asthma. The last group includes asthma for which control is not achieved despite the highest level of recommended treatment and asthma for which control can be maintained only with the highest level of recommended treatment.
KW - Asthma
KW - Control
KW - Definition
KW - GARD
KW - Risk
KW - Severity
UR - http://www.scopus.com/inward/record.url?scp=78049457548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78049457548&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2010.07.019
DO - 10.1016/j.jaci.2010.07.019
M3 - Article
C2 - 20926125
AN - SCOPUS:78049457548
SN - 0091-6749
VL - 126
SP - 926
EP - 938
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 5
ER -